Cargando…
Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
It is well established that the PTEN (Phosphatase and Tensin Homolog) mutant is a frequently mutated gene found in clear cell renal cell carcinoma (ccRCC), making it a potential biomarker for individualized treatment opinions. Here, in the present study, we designed a method to evaluate the signific...
Autores principales: | Fan, Caibin, Zhao, Chunchun, Wang, Fei, Li, Shugen, Wang, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518664/ https://www.ncbi.nlm.nih.gov/pubmed/31139560 http://dx.doi.org/10.3389/fonc.2019.00357 |
Ejemplares similares
-
Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019) -
Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis
por: Sun, Jian, et al.
Publicado: (2019) -
EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis
por: Sun, Chenmin, et al.
Publicado: (2018) -
Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022) -
Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)